1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with Glial Cell Tumors in 1 studies
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol: a sphingolipid analog; inhibits the enzyme activity in infected erythrocytes
N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide : A fatty amide resulting from the formal condensation of palmitic acid with the primary amino group of 2-amino-3-(morpholin-4-yl)-1-phenylpropan-1-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We here investigated the role of ceramide metabolism for the resistance of glioma cells to treatment with the chemotherapeutic drug, gemcitabine." | 3.75 | Ceramide metabolism determines glioma cell resistance to chemotherapy. ( Dumitru, CA; Gulbins, E; Weller, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumitru, CA | 1 |
| Weller, M | 1 |
| Gulbins, E | 1 |
1 other study available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and Glial Cell Tumors
| Article | Year |
|---|---|
Ceramide metabolism determines glioma cell resistance to chemotherapy.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Ceramides; Deo | 2009 |